Home/Filings/4/0001628280-25-056331
4//SEC Filing

Brumm Joshua T 4

Accession 0001628280-25-056331

CIK 0001253689other

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 4:35 PM ET

Size

5.5 KB

Accession

0001628280-25-056331

Insider Transaction Report

Form 4
Period: 2025-12-08
Brumm Joshua T
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-12-08+345,672345,672 total
    Exercise: $13.17Exp: 2035-12-08Ordinary Shares (345,672 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase shares of the Issuer's ordinary shares and vests in 48 approximately equal monthly installments that commenced on December 8, 2025.

Issuer

CRESCENT BIOPHARMA, INC.

CIK 0001253689

Entity typeother

Related Parties

1
  • filerCIK 0001528826

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:35 PM ET
Size
5.5 KB